SEC Tracker
Get the app

THC Therapeutics

THCT

Revenue $0, basic EPS −$0.02 in the year ended Jul 31, 2024, from a 10-K filed .

Get email alertsGet the app
Legal name
THC Therapeutics, Inc.
CIK
1404935
Sector
Industrials and machinery

Major8-K filed

THC Therapeutics terminated a share exchange agreement

  • Terminated Share Exchange Agreement with ST Holdings on Oct 30, 2026
  • Amended preferred stock designations with 500,000 Series D shares
  • Series D shares convert to common stock at $0.01 per share

Read the 8-K on EDGARTables over time

Get an email when THC Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

All filings

Results, 8-Ks and Major or Notable filings come first, then registrations and share actions, then everything else, newest first. Routine filings are kept here unmarked; insider filings are summed up in one line.

Older filings on EDGAR

Listing compliance

No listing notices in the 8-K item 3.01 filings SEC Tracker has read.

Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. All open notices

Trading halts

No trading halts for THCT since Feb 22, 2019, when SEC Tracker began reading the Nasdaq Trader feed.

Halt times and codes from the Nasdaq Trader trade halts feed, which lists Nasdaq and other exchange halts. Filings matched by SEC Tracker from EDGAR by company and time. Not investment advice. All recent halts

THC Therapeutics shares and listing

From the company's own filings; each row names its source. Not investment advice.

  • Shares outstandingas of Feb 10, 2026 (10-K filed Feb 27)40.3Mwarrants, notes and options not read yet, so fully diluted is not known
  • Listing compliance8-K item 3.01No noticesin the filings read